ENTREMED INC
10-Q, EX-27.1, 2000-11-13
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ENTREMED INC, 10-Q, 2000-11-13
Next: PLM EQUIPMENT GROWTH & INCOME FUND VII, 10-Q, 2000-11-13



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED BALANCE SHEETS AND THE CONDENSED CONSOLIDATED STATEMENTS
OF OPERATIONS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                      37,987,956
<SECURITIES>                                         0
<RECEIVABLES>                                  996,042
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            39,355,770
<PP&E>                                       7,614,836
<DEPRECIATION>                               3,093,528
<TOTAL-ASSETS>                              44,653,622
<CURRENT-LIABILITIES>                        7,290,727
<BONDS>                                      1,256,034
                                0
                                          0
<COMMON>                                       170,989
<OTHER-SE>                                  36,089,137
<TOTAL-LIABILITY-AND-EQUITY>                44,653,622
<SALES>                                              0
<TOTAL-REVENUES>                             2,447,810
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            39,040,558
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             167,805
<INCOME-PRETAX>                           (35,055,910)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (35,055,910)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (35,055,910)
<EPS-BASIC>                                     (2.22)
<EPS-DILUTED>                                   (2.22)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission